Targeting LGR5 + cells with an antibody-drug conjugate for the treatment of colon cancer
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
An antibody-drug conjugate targeting LGR5 effectively treats intestinal cancer in preclinical models.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, LGR5-targeted antibody–drug conjugates were demonstrated to induce cytotoxicity in LGR5-high gastrointestinal cancer cells and decrease tumor size and proliferation in colon cancer xenograft models [181,182].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [181]
Citations
Cites
Identification of stem cells in small intestine and colon by marker gene Lgr5
Barker, N., van Es, J. H., Kuipers, J., Kujala, P., van den Born, M., Cozijnsen, M., Haegebarth, A., Korving, J., Begthel, H., Peters, P. J., et al. (2007) · Nature · doi:10.1038/nature06196 · Cited by 5,687 · cited 3×
“These findings support previously published work indicating that Lgr5 cells continuously contribute to an established tumor mass in the setting of the Apc mutation (4, 5).”
BackgroundResultInfluentialaffy—analysis of Affymetrix GeneChip data at the probe level
Gautier, L., Cope, L., Bolstad, B. M., & Irizarry, R. A. (2004) · Bioinformatics · doi:10.1093/bioinformatics/btg405 · Cited by 5,218
Crypt stem cells as the cells-of-origin of intestinal cancer
Barker, N., Ridgway, R. A., van Es, J. H., van de Wetering, M., Begthel, H., van den Born, M., Danenberg, E., Clarke, A. R., Sansom, O. J., & Clevers, H. (2009) · Nature · doi:10.1038/nature07602 · Cited by 2,166
Humanization of an anti-p185HER2 antibody for human cancer therapy.
Carter, P., Presta, L., Gorman, C. M., Ridgway, J. B., Henner, D., Wong, W. L., Rowland, A. M., Kotts, C., Carver, M. E., & Shepard, H. M. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4285 · Cited by 1,918
Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras
Jackson, E. L., Willis, N., Mercer, K., Bronson, R. T., Crowley, D., Montoya, R., Jacks, T., & Tuveson, D. A. (2001) · Genes & Development · doi:10.1101/gad.943001 · Cited by 1,898
A Dominant Mutation That Predisposes to Multiple Intestinal Neoplasia in the Mouse
Moser, A. R., Pitot, H. C., & Dove, W. F. (1990) · Science · doi:10.1126/science.2296722 · Cited by 1,591 · cited 2×
“To enable such a model, we combined the APCmin model of intestinal tumorigenesis with conditional mutant KrasG12D expression under the control of the intestinal specific VillinCre (7, 19, 20).”
MethodIn vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration
Huch, M., Dorrell, C., Boj, S. F., van Es, J. H., Li, V. S. W., van de Wetering, M., Sato, T., Hamer, K., Sasaki, N., Finegold, M. J., et al. (2013) · Nature · doi:10.1038/nature11826 · Cited by 1,555 · cited 3×
“scencem agorg/ D ow nladed from shown to increase after liver damage and appear to participate in tissue repair (11).”
BackgroundResultInfluentialSite-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index
Junutula, J. R., Raab, H., Clark, S., Bhakta, S., Leipold, D. D., Weir, S., Chen, Y., Simpson, M., Tsai, S. P., Dennis, M. S., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt.1480 · Cited by 1,382
Self-citationA reserve stem cell population in small intestine renders Lgr5-positive cells dispensable
Tian, H., Biehs, B., Warming, S., Leong, K. G., Rangell, L., Klein, O. D., & de Sauvage, F. J. (2011) · Nature · doi:10.1038/nature10408 · Cited by 1,204
Cancer stem cells: an evolving concept
Nguyen, L. V., Vanner, R., Dirks, P., & Eaves, C. J. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3184 · Cited by 1,171
Lineage Tracing Reveals Lgr5 + Stem Cell Activity in Mouse Intestinal Adenomas
Schepers, A. G., Snippert, H. J., Stange, D. E., van den Born, M., van Es, J. H., van de Wetering, M., & Clevers, H. (2012) · Science · doi:10.1126/science.1224676 · Cited by 1,072
Tissue‐specific and inducible Cre‐mediated recombination in the gut epithelium
El Marjou, F., Janssen, K., Hung‐Junn Chang, B., Li, M., Hindie, V., Chan, L., Louvard, D., Chambon, P., Metzger, D., & Robine, S. (2004) · genesis · doi:10.1002/gene.20042 · Cited by 1,060
The Lgr5 intestinal stem cell signature: robust expression of proposed quiescent ‘+4’ cell markers
Muñoz, J., Stange, D. E., Schepers, A. G., van de Wetering, M., Koo, B., Itzkovitz, S., Volckmann, R., Kung, K. S., Koster, J., Radulescu, S., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.166 · Cited by 772
Senter, P. D., & Sievers, E. L. (2012) · Nature Biotechnology · doi:10.1038/nbt.2289 · Cited by 763
Lgr5 stem cells are indispensable for radiation-induced intestinal regeneration
Metcalfe, C., Kljavin, N. M., Ybarra, R., & de Sauvage, F. J. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2013.11.008 · Cited by 575 · cited 1×
“Moreover, the increased damage to surrounding tissue could also alter the dependence of tissues such as gut on LGR5 cells, as has been shown for intestinal regeneration after acute radiation-induced damage (28).”
BackgroundDclk1 distinguishes between tumor and normal stem cells in the intestine
Nakanishi, Y., Seno, H., Fukuoka, A., Ueo, T., Yamaga, Y., Maruno, T., Nakanishi, N., Kanda, K., Komekado, H., Kawada, M., et al. (2013) · Nature Genetics · doi:10.1038/ng.2481 · Cited by 406
Wnt Signaling, Lgr5, and Stem Cells in the Intestine and Skin
Haegebarth, A., & Clevers, H. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.080758 · Cited by 353
Tijink, B. M., Buter, J., de Bree, R., Giaccone, G., Lang, M. S., Staab, A., Leemans, C. R., & van Dongen, G. A. M. S. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0910 · Cited by 315
Janssen, K., Alberici, P., Fsihi, H., Gaspar, C., Breukel, C., Franken, P., Rosty, C., Abal, M., El Marjou, F., Smits, R., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.08.011 · Cited by 298
Maturing antibody–drug conjugate pipeline hits 30
Mullard, A. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4009 · Cited by 295
Polson, A. G., Calemine-Fenaux, J., Chan, P., Chang, W., Christensen, E., Clark, S., de Sauvage, F. J., Eaton, D., Elkins, K., Elliott, J. M., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2250 · Cited by 252
Self-citationLgr5 marks stem/progenitor cells in ovary and tubal epithelia
Ng, A., Tan, S., Singh, G., Rizk, P., Swathi, Y., Tan, T. Z., Huang, R. Y.-J., Leushacke, M., & Barker, N. (2014) · Nature Cell Biology · doi:10.1038/ncb3000 · Cited by 218
Automated Selection of DAB-labeled Tissue for Immunohistochemical Quantification
Brey, E. M., Lalani, Z., Johnston, C., Wong, M., McIntire, L. V., Duke, P. J., & Patrick, C. W. (2003) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540305100503 · Cited by 200
Sansom, O. J., Meniel, V., Wilkins, J. A., Cole, A. M., Oien, K. A., Marsh, V., Jamieson, T. J., Guerra, C., Ashton, G. H., Barbacid, M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604130103 · Cited by 187
McClanahan, T., Koseoglu, S., Smith, K., Grein, J., Gustafson, E., Black, S., Kirschmeier, P., & Samatar, A. A. (2006) · Cancer Biology & Therapy · doi:10.4161/cbt.5.4.2521 · Cited by 181
Oroudjev, E., Lopus, M., Wilson, L., Audette, C., Provenzano, C., Erickson, H., Kovtun, Y., Chari, R., & Jordan, M. A. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0645 · Cited by 164
In situ validation of an intestinal stem cell signature in colorectal cancer
Ziskin, J. L., Dunlap, D. Y., Yaylaoglu, M., Fodor, I. K., Forrest, W. F., Patel, R., Ge, N., Hutchins, G. G. A., Pine, J. K., Quirke, P., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-301195 · Cited by 119
Li, D., Poon, K. A., Yu, S.-F., Dere, R., Go, M., Lau, J., Zheng, B., Elkins, K., Danilenko, D., Kozak, K. R., et al. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-1173 · Cited by 85
Self-citationLymph node-independent liver metastasis in a model of metastatic colorectal cancer
Enquist, I. B., Good, Z., Jubb, A. M., Fuh, G., Wang, X., Junttila, M. R., Jackson, E. L., & Leong, K. G. (2014) · Nature Communications · doi:10.1038/ncomms4530 · Cited by 70
Self-citationToxicity of dolastatin 10 in mice, rats and dogs and its clinical relevance
Mirsalis, J. C., Schindler‐Horvat, J., Hill, J. R., Tomaszewski, J. E., Donohue, S. J., & Tyson, C. A. (1999) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050995 · Cited by 50
Fourth World Antibody-Drug Conjugate Summit: February 29–March 1, 2012, Frankfurt, Germany
Beck, A., Lambert, J. M., Sun, M. M. C., & Lin, K. (2012) · mAbs · doi:10.4161/mabs.21697 · Cited by 41
Quintieri, L., Fantin, M., Palatini, P., Martin, S. D., Rosato, A., Caruso, M., Geroni, C., & Floreani, M. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.07.003 · Cited by 24
Cited by
Batlle, E., & Clevers, H. (2017) · Nature Medicine · doi:10.1038/nm.4409 · Cited by 2,769
Cancer stem cells—Origins and biomarkers: Perspectives for targeted personalized therapies
Walcher, L., Kistenmacher, A.-K., Suo, H., Kitte, R., Dluczek, S., Strauß, A., Blaudszun, A.-R., Yevsa, T., Fricke, S., & Kossatz-Boehlert, U. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01280 · Cited by 1,007
Intra-tumor heterogeneity from a cancer stem cell perspective
Prasetyanti, P. R., & Medema, J. P. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0600-4 · Cited by 800
A distinct role for Lgr5+ stem cells in primary and metastatic colon cancer
de Sousa e Melo, F., Kurtova, A. V., Harnoss, J. M., Kljavin, N., Hoeck, J. D., Hung, J., Anderson, J. E., Storm, E. E., Modrusan, Z., Koeppen, H., et al. (2017) · Nature · doi:10.1038/nature21713 · Cited by 788
Visualization and targeting of LGR5+ human colon cancer stem cells
Shimokawa, M., Ohta, Y., Nishikori, S., Matano, M., Takano, A., Fujii, M., Date, S., Sugimoto, S., Kanai, T., & Sato, T. (2017) · Nature · doi:10.1038/nature22081 · Cited by 728
Metadata
- Authors
- Junttila, M. R., Mao, W., Wang, X., Wang, B.-E., Pham, T., Flygare, J., Yu, S.-F., Yee, S., Goldenberg, D., Fields, C., Eastham-Anderson, J., Singh, M., Vij, R., Hongo, J.-A., Firestein, R., Schutten, M., Flagella, K., Polakis, P., & Polson, A. G.
- Affiliations
- Genentech (US)
- Research and Early Development, Genentech Inc., 1 DNA Way, South San Francisco, CA 94080, USA.
- Corresponding author
- Junttila, Melissa R.
- Singh, Mallika
- Firestein, Ron
- Flagella, Kelly
- Polson, Andrew G.
- ORCID
- Venue
- Science Translational Medicine
- Published
- 2015-11-18
- Volume
- 7
- Issue
- 314
- Pages
- 314ra186-314ra186
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2174197315
- Cited by
- 182
- References
- 32
- Citations by year
- 2026: 9 · 2025: 20 · 2024: 19 · 2023: 17 · 2022: 7 · 2021: 23 · 2020: 19 · 2019: 20 · 2018: 24 · 2017: 13 · 2016: 10 · 2015: 1
- FWCI
- 6.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Genentech Inc.
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
- Keywords
- Lgr5, antibody-drug conjugates, colon cancer, cancer stem cells, tissue stem cells, targeted cancer therapy, G protein-coupled receptors, genetically engineered mouse models, intestinal tumorigenesis, tumor growth inhibition, drug safety
- MeSH terms
- Animals, Immunotoxins, Antineoplastic Agents, Colonic Neoplasms, Dose-Response Relationship, Drug, Feasibility Studies, Female, Male, Mice, Inbred C57BL, Mice, Nude, Mice, Transgenic, Time Factors, Neoplastic Stem Cells, Gene Expression Regulation, Neoplastic, Rats, Sprague-Dawley, Genes, APC, Inhibitory Concentration 50, Xenograft Model Antitumor Assays, Receptors, G-Protein-Coupled, Cell Line, Tumor, Cell Proliferation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.